BGI Americas Corporation

Call
Website
1 Broadway Ste 3
Cambridge, MA 02142
+1 (617) 500-2741
https://bgiamericas.com

BGI Americas Corporation, based in Cambridge, MA, offers the Palisis platform, an all-in-one ticketing and reservation system designed to simplify operations for the travel industry. With seamless integrations to over 200 partners and a focus on streamlined business management, Palisis empowers companies to enhance their sales reach and improve customer experiences.

Catering to various sectors, including sightseeing buses, tourist trains, and attractions, Palisis supports organizations by effectively managing ticket sales, reservations, and customer information in one unified solution. The platform's robust features enable businesses to tap into a wider market while reducing administrative burdens, allowing operators to focus on enhancing visitor engagement and maximizing profits.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Factor Bioscience Inc

Factor Bioscience Inc., located in Cambridge, MA, is devoted to advancing cell engineering to address diseases and elevate health standards. With over a decade of experience and a robust portfolio of more than 150 patents, the company focuses on developing transformative allogeneic cell therapies leveraging innovative technologies in mRNA gene editing, cell reprogramming, and nucleic acid delivery. The organization emphasizes collaboration with strategic partners throughout all stages of product development, from initial research to manufacturing support. Factor Bioscience aims to harness the potential of cell engineering in revolutionizing medicine for millions of patients, believing that their work can significantly impact the treatment and management of various health conditions, including cancer and rare diseases. Generated from the website
Drugs acting on the respiratory system, Vitamin, nutrient, and hematinic preparations for human use

Akebia Therapeutics, Inc

Akashi Therapeutics, based in Cambridge, is a global biopharmaceutical company with a focus on developing innovative therapies for individuals affected by rare disorders. The company's mission is to create life-changing treatments that address the unmet medical needs of those living with rare diseases, aiming to improve the quality of life for patients worldwide. Generated from their website's infomation
Drugs acting on the respiratory system, Blood derivatives, Surgical instruments and apparatus

Relay Therapeutics

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.
United States›Massachusetts›Cambridge›BGI Americas Corporation

Partial Data by Infogroup (c) 2025. All rights reserved.

Partial Data by Foursquare.